Brabender J - Search Results

1

Osteopontin but not osteonectin messenger RNA expression is a prognostic marker in curatively resected non-small cell lung cancer.

Schneider S, Yochim J, Brabender J, Uchida K, Danenberg KD, Metzger R, Schneider PM, Salonga D, Hölscher AH, Danenberg PV. Schneider S, et al. Among authors: brabender j. Clin Cancer Res. 2004 Mar 1;10(5):1588-96. doi: 10.1158/1078-0432.ccr-0565-3. Clin Cancer Res. 2004. PMID: 15014008

2

The role of retinoid X receptor messenger RNA expression in curatively resected non-small cell lung cancer.

Brabender J, Danenberg KD, Metzger R, Schneider PM, Lord RV, Groshen S, Tsao-Wei DD, Park J, Salonga D, Hölscher AH, Danenberg PV. Brabender J, et al. Clin Cancer Res. 2002 Feb;8(2):438-43. Clin Cancer Res. 2002. PMID: 11839661

3

Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer.

Brabender J, Park J, Metzger R, Schneider PM, Lord RV, Hölscher AH, Danenberg KD, Danenberg PV. Brabender J, et al. Ann Surg. 2002 Mar;235(3):440-3. doi: 10.1097/00000658-200203000-00017. Ann Surg. 2002. PMID: 11882767 Free PMC article.

4

Glutathione S-transferase-pi expression is downregulated in patients with Barrett's esophagus and esophageal adenocarcinoma.

Brabender J, Lord RV, Wickramasinghe K, Metzger R, Schneider PM, Park JM, Hölscher AH, DeMeester TR, Danenberg KD, Danenberg PV. Brabender J, et al. J Gastrointest Surg. 2002 May-Jun;6(3):359-67. doi: 10.1016/s1091-255x(02)00003-3. J Gastrointest Surg. 2002. PMID: 12022988

5

Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

Lord RV, Brabender J, Gandara D, Alberola V, Camps C, Domine M, Cardenal F, Sánchez JM, Gumerlock PH, Tarón M, Sánchez JJ, Danenberg KD, Danenberg PV, Rosell R. Lord RV, et al. Among authors: brabender j. Clin Cancer Res. 2002 Jul;8(7):2286-91. Clin Cancer Res. 2002. PMID: 12114432 Clinical Trial.

6

Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome.

Brabender J, Usadel H, Metzger R, Schneider PM, Park J, Salonga D, Tsao-Wei DD, Groshen S, Lord RV, Takebe N, Schneider S, Hölscher AH, Danenberg KD, Danenberg PV. Brabender J, et al. Clin Cancer Res. 2003 Jan;9(1):223-7. Clin Cancer Res. 2003. PMID: 12538473

7

Thymidylate synthase expression in advanced colorectal cancer predicts for response to raltitrexed.

Farrugia DC, Ford HE, Cunningham D, Danenberg KD, Danenberg PV, Brabender J, McVicar AD, Aherne GW, Hardcastle A, McCarthy K, Jackman AL. Farrugia DC, et al. Among authors: brabender j. Clin Cancer Res. 2003 Feb;9(2):792-801. Clin Cancer Res. 2003. PMID: 12576452 Clinical Trial.

8

High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer.

Warnecke-Eberz U, Metzger R, Miyazono F, Baldus SE, Neiss S, Brabender J, Schaefer H, Doerfler W, Bollschweiler E, Dienes HP, Mueller RP, Danenberg PV, Hoelscher AH, Schneider PM. Warnecke-Eberz U, et al. Among authors: brabender j. Clin Cancer Res. 2004 Jun 1;10(11):3794-9. doi: 10.1158/1078-0432.CCR-03-0079. Clin Cancer Res. 2004. PMID: 15173087

9

Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer.

Schneider S, Uchida K, Brabender J, Baldus SE, Yochim J, Danenberg KD, Salonga D, Chen P, Tsao-Wei D, Groshen S, Hoelscher AH, Schneider PM, Danenberg PV. Schneider S, et al. Among authors: brabender j. J Am Coll Surg. 2005 Mar;200(3):336-44. doi: 10.1016/j.jamcollsurg.2004.10.035. J Am Coll Surg. 2005. PMID: 15737843

10

Sex differences in the predictive power of the molecular prognostic factor HER2/neu in patients with non-small-cell lung cancer.

Vallböhmer D, Brabender J, Yang DY, Danenberg K, Schneider PM, Metzger R, Holscher AH, Danenberg PV. Vallböhmer D, et al. Among authors: brabender j. Clin Lung Cancer. 2006 Mar;7(5):332-7. doi: 10.3816/clc.2006.n.015. Clin Lung Cancer. 2006. PMID: 16640805

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page